Generic medication for chronic kidney disease authorised in Romania

Elderly patients in Romania living with chronic kidney disease now have access to a new, more affordable treatment option. Health authorities have recently granted a marketing authorisation for a generic medicine based on cinacalcet, an active substance that plays a crucial role in treating serious metabolic imbalances.

This decision is welcome news for the thousands of older patients who require long-term treatment for chronic kidney conditions. The introduction of the generic version not only improves access to therapy but also helps reduce treatment costs — a vital consideration for elderly patients on limited incomes.

Essential benefits for older patients with kidney problems

For elderly patients on dialysis, managing hormonal and mineral balance becomes a critical priority. Cinacalcet works by regulating parathyroid hormone and blood calcium levels, thereby preventing serious complications that can affect the skeletal and cardiovascular systems.

The active substance belongs to the calcimimetic class and works by improving the sensitivity of calcium receptors in the parathyroid glands. This mechanism of action enables effective control of the mineral disorders that frequently affect elderly patients with advanced renal failure.

Multiple therapeutic applications

The medicine has been authorised for the treatment of several complex medical conditions that particularly affect the senior population:

• Secondary hyperparathyroidism in patients with severe kidney disease requiring dialysis
• Reduction of elevated calcium levels in patients with parathyroid tumours
• Control of hypercalcaemia in patients with primary hyperparathyroidism when surgery is not a viable option

These indications highlight the importance of the medicine in managing chronic conditions that require constant monitoring and long-term treatment — aspects that are a common feature of senior care.

The availability of this generic alternative represents an important step forward in improving access to quality treatments for elderly patients. Reduced treatment costs can have a significant impact on the quality of life of older people and the families who care for them, offering an effective and more financially accessible therapeutic option for managing these complex medical conditions.